XRAY vs ATRC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

XRAY

43.0
AI Score
VS
XRAY Wins

ATRC

37.1
AI Score

Investment Advisor Scores

XRAY

43score
Recommendation
HOLD

ATRC

37score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY ATRC Winner
Forward P/E 6.4392 227.2727 XRAY
PEG Ratio 0.6439 10 XRAY
Revenue Growth -7.5% 15.0% ATRC
Earnings Growth 15.2% 0.0% XRAY
Tradestie Score 43.0/100 37.1/100 XRAY
Profit Margin -3.4% 2.5% ATRC
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY XRAY

Relative Price Performance (Last 90 Days)

XRAY 1M: +14.8% · 3M: -15.7% ATRC 1M: +1.2% · 3M: +32.3%

Current Technical Phase

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.0 · Price: $9.76

ATRC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.8 · Price: $57.53

Fundamentals Snapshot

Metric XRAY ATRC
Market Cap — —
Forward P/E 7.8 125.0
Trailing P/E — 181.5
Revenue (TTM) — —
Revenue Growth -0.1% 0.2%
Gross Margin 0.5% 0.8%
Operating Margin 0.0% 0.0%
EPS -0.61 0.31
Dividend Yield 0.02% —

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.